SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8: 43545.
  • 2
    Rasmussen T, McCann W. Clinical studies of patients with focal epilepsy due to “chronic encephalitis.” Trans Am Neurol Assoc 1968;93: 8994.
  • 3
    Oguni H, Andermann F, Rasmussen T. The natural history of the chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. In: AndermannF, ed. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Boston : Butterworth-Heinemann, 1991: 736.
  • 4
    Vining EP, Freeman JM, Brandt J, et al. Progressive unilateral encephalopathy of childhood (Rasmussen's syndrome): a reappraisal. Epilepsia 1993;34: 63950.
  • 5
    Oguni H, Andermann F, Rasmussen TB. The syndrome of chronic encephalitis and epilepsy: a study based on the MNI series of 48 cases. Adv Neurol 1992;57: 41933.
  • 6
    Robitaille Y. Neuropathological aspects of chronic encephalitis. In: AndermannF, ed. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Boston : Butterworth-Heinemann, 1991: 79110.
  • 7
    Honavar M, Janota I, Polkey CE. Rasmussen's encephalitis in surgery for epilepsy. Dev Med Child Neurol 1992;34: 314.
  • 8
    Vining E. Rasmussen's syndrome. In: KotagalP, LudersH, eds. The epilepsies: etiologies and prevention. San Diego : Academic Press, 1999: 2838.
  • 9
    Vining EP, Freeman JM, Pillas DJ, et al. Why would you remove half a brain? The outcome of 58 children after hemispherectomy: the Johns Hopkins experience: 1968 to 1996. Pediatrics 1997;100: 16371.
  • 10
    Farrell MA, Droogan O, Secor DL, et al. Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol (Berl) 1995;89: 31321.
  • 11
    Carson BS, Javedan SP, Freeman JM, et al. Hemispherectomy: a hemidecortication approach and review of 52 cases. J Neurosurg 1996;84: 90311.
  • 12
    Boatman D, Freeman J, Vining E, et al. Language recovery after left hemispherectomy in children with late-onset seizures. Ann Neurol 1999;46: 57986.
  • 13
    Furuta A, Price DL, Pardo CA, et al. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 1995;146: 35767.
  • 14
    Graeber MB, Streit WJ, Kreutzberg GW. The third glial cell type: the microglia: cellular markers of activation in situ. Acta Histochem Suppl 1990;38: 15760.
  • 15
    Petito CK, Morgello S, Felix JC, et al. The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab 1990;10: 8509.
  • 16
    Gehrmann J, Bonnekoh P, Miyazawa T, et al. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 1992;12: 25769.
  • 17
    Bien CG, Urbach H, Deckert M, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology 2002;58: 2507.
  • 18
    Olney JW. Excitotoxicity: an overview. Can Dis Wkly Rep 1990;16(suppl 1E):4757.
  • 19
    Lassmann H. The pathology of multiple sclerosis and its evolution. Trans R Soc Lond B Biol Sci 1999;354: 163540.
  • 20
    Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47: 70717.
  • 21
    Dale RC, De Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123: 240722.
  • 22
    Lassmann H. Classification of demyelinating diseases at the interface between etiology and pathogenesis. Curr Opin Neurol 2001;14: 2538.
  • 23
    Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001;7: 11521.
  • 24
    Asher DM, Gajdusek DC. Virologic studies in chronic encephalitis. In: AndermannF, ed. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Boston : Butterworth-Heinemann, 1991: 14758.
  • 25
    Vinters HV, Wang R, Wiley CA. Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Hum Pathol 1993;24: 8719.
  • 26
    Atkins MR, Terrell W, Hulette CM. Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol 1995;14: 712.
  • 27
    Park SH, Vinters HV. Ultrastructural study of Rasmussen encephalitis. Ultrastruct Pathol 2002;26: 28792.
  • 28
    Corsellis JA, Bruton CJ. Neuropathology of status epilepticus in humans. Adv Neurol 1983;34: 12939.
  • 29
    Pollard H, Cantagrel S, Charriaut-Marlangue C, et al. Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 1994;5: 10535.
  • 30
    Kubova H, Druga R, Lukasiuk K, et al. Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 2001;21: 35939.
  • 31
    Li Y, Uccelli A, Laxer KD, et al. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 1997;158: 142837.
  • 32
    Pardo CA, Arroyo S, Vining E, et al. Neuronal injury in Rasmussen's chronic encephalitis is mediated by cytotoxic T-cells. Epilepsia 1994;35(suppl 8):89.
  • 33
    Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002;51: 3118.
  • 34
    Villemure JG, Andermann F, Rasmussen T. Hemispherectomy for the treatment of epilepsy due to chronic encephalitis. In: AndermannF, ed. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Boston : Butterworth-Heinemann, 1991: 23544.
  • 35
    Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002;125: 17519.